-
Product Insights
Likelihood of Approval and Phase Transition Success Rate Model – ABBV-932 in Generalized Anxiety Disorder (GAD)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - ABBV-932 in Generalized Anxiety Disorder (GAD) report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. ABBV-932 in Generalized Anxiety Disorder (GAD) Drug Details: ABBV-932 is...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – PT-00114 in Generalized Anxiety Disorder (GAD)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - PT-00114 in Generalized Anxiety Disorder (GAD) report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. PT-00114 in Generalized Anxiety Disorder (GAD) Drug Details: PT-00114 (TCAP-1)...
-
Product Insights
NewNet Present Value Model: Merck & Co Inc’s Nemtabrutinib
Empower your strategies with our Net Present Value Model: Merck & Co Inc's Nemtabrutinib report and make more profitable business decisions. Evaluating the value of drugs can be complex, involving a deep understanding of the drug, the current market and expected cash flows, expenses, and success rates at each stage of development. Fortunately, GlobalData simplifies this process with meticulously crafted, high-value, risk-adjusted NPV models that incorporate extensive drug intelligence.
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Ulotaront Hydrochloride in Psychosis
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Ulotaront Hydrochloride in Psychosis report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Ulotaront Hydrochloride in Psychosis Drug Details: Ulotaront hydrochloride (SEP-363856, SEP-856) is...
-
Product Insights
Likelihood of Approval and Phase Transition Success Rate Model – Ulotaront Hydrochloride in Major Depressive Disorder
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Ulotaront Hydrochloride in Major Depressive Disorder report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Ulotaront Hydrochloride in Major Depressive Disorder Drug Details: Ulotaront hydrochloride...
-
Product Insights
Likelihood of Approval and Phase Transition Success Rate Model – Ulotaront Hydrochloride in Parkinson’s Disease
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Ulotaront Hydrochloride in Parkinson's Disease report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Ulotaront Hydrochloride in Parkinson's Disease Drug Details: Ulotaront hydrochloride (SEP-363856, SEP-856)...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Ulotaront Hydrochloride in Schizophrenia
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Ulotaront Hydrochloride in Schizophrenia report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Ulotaront Hydrochloride in Schizophrenia Drug Details: Ulotaront hydrochloride (SEP-363856, SEP-856) is...
-
Product Insights
Likelihood of Approval and Phase Transition Success Rate Model – AAV-GAD in Parkinson’s Disease
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - AAV-GAD in Parkinson's Disease report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data.AAV-GAD in Parkinson's DiseaseDrug Details:AAV-GAD is under development for the treatment of Parkinson's...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Deuterated etifoxine in Generalized Anxiety Disorder (GAD)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Deuterated etifoxine in Generalized Anxiety Disorder (GAD) report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Deuterated etifoxine in Generalized Anxiety Disorder (GAD) Drug Details:...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – AVN-101 in Generalized Anxiety Disorder (GAD)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - AVN-101 in Generalized Anxiety Disorder (GAD) report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data.AVN-101 in Generalized Anxiety Disorder (GAD) Drug Details:AVN-101 is under development...